The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy

A. M. Gianni, S. Siena, M. Bregni, G. Bonadonna

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)956
Number of pages1
JournalPathologie Biologie
Volume39
Issue number9
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this